StockData
IM Cannabis Corp. logo

IM Cannabis Corp. (IMCC) stock

IMCCNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 30, 2026Score 4/30
$0.54+0.04 (+8.49%)

Close on Nov 18, 2026Market cap $3.16MP/E –Yield –

IM Cannabis gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

For fiscal 2025 it was C$9.69M, up 14.6% from the year before. The highest annual figure on record is C$10.47M in fiscal 2020.

Annual gross profit

PeriodPeriod endValueChange
FY2025Dec 31, 2025C$9.69M+14.6%
FY2024Dec 31, 2024C$8.45M-14.2%
FY2023Dec 31, 2023C$9.85M+7.5%
FY2022Dec 31, 2022C$9.16M+44.7%
FY2021Dec 31, 2021C$6.33M-39.5%
FY2020Dec 31, 2020C$10.47M+166.4%
FY2019Dec 31, 2019C$3.93M–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026C$1.51M-31.6%
Q2 FY2025Jun 30, 2025C$3.43M–
Q2 FY2024Jun 30, 2024C$844.00K–
Q2 FY2023Jun 30, 2023C$3.46M–
Q2 FY2022Jun 30, 2022C$2.20M–
Q2 FY2021Jun 30, 2021-C$568.00K–

More IM Cannabis figures

See a number that looks wrong?